ResearcherShanghai Jiao Tong UniversityActive in the last 2 years
Dian-na Gu
Matched on ORCID iD 0000-0002-2324-9920; OpenAlex author ID A5034775273. Sources: OpenAlex.
Their work
- Papers
- 8 (first author 0, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 8
2016: 1 paper · 2017: 1 paper · 2018: 1 paper · 2019: none · 2020: 2 papers · 2021: 2 papers · 2022: none · 2023: none · 2024: 1 paper
Papers 8
- Pancreatic cancer cells hijack tumor suppressive microRNA-26a to promote radioresistance and potentiate tumor repopulation. Co-author DOI 10.1016/j.heliyon.2024.e31346↗
- Correction to: microRNA-193a stimulates pancreatic cancer cell repopulation and metastasis through modulating TGF-β2/TGF-βRIII signalings. Co-author DOI 10.1186/s13046-021-02180-6↗
- MicroRNA-7 modulates cellular senescence to relieve gemcitabine resistance by targeting PARP1/NF-κB signaling in pancreatic cancer cells. Last author DOI 10.3892/ol.2020.12400↗
- MicroRNA-7 as a Potential Biomarker for Prognosis in Pancreatic Cancer. Last author DOI 10.1155/2020/2782101↗
- Dying tumor cell-derived exosomal miR-194-5p potentiates survival and repopulation of tumor repopulating cells upon radiotherapy in pancreatic cancer. Co-author DOI 10.1186/s12943-020-01178-6↗
- microRNA-193a stimulates pancreatic cancer cell repopulation and metastasis through modulating TGF-β2/TGF-βRIII signalings. Co-author DOI 10.1186/s13046-018-0697-3↗
- microRNA-7 impairs autophagy-derived pools of glucose to suppress pancreatic cancer progression. Co-author DOI 10.1016/j.canlet.2017.04.020↗
- Aspirin in pancreatic cancer: chemopreventive effects and therapeutic potentials. Co-author DOI 10.1016/j.bbcan.2016.08.002↗
Closest collaborators
The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Mingjie Jiang · 7 shared papers, 2016–2024 · strength 0.90
- Paper Pancreatic cancer cells hijack tumor suppressive microRNA-26a to promote radioresistance and potentiate tumor repopulat… DOI 10.1016/j.heliyon.2024.e31346↗
- Paper Correction to: microRNA-193a stimulates pancreatic cancer cell repopulation and metastasis through modulating TGF-β2/TG… DOI 10.1186/s13046-021-02180-6↗
- Paper MicroRNA-7 as a Potential Biomarker for Prognosis in Pancreatic Cancer. DOI 10.1155/2020/2782101↗
- Ling Tian · 5 shared papers, 2017–2021 · strength 0.59
- Paper MicroRNA-7 modulates cellular senescence to relieve gemcitabine resistance by targeting PARP1/NF-κB signaling in pancre… DOI 10.3892/ol.2020.12400↗
- Paper Correction to: microRNA-193a stimulates pancreatic cancer cell repopulation and metastasis through modulating TGF-β2/TG… DOI 10.1186/s13046-021-02180-6↗
- Paper Dying tumor cell-derived exosomal miR-194-5p potentiates survival and repopulation of tumor repopulating cells upon rad… DOI 10.1186/s12943-020-01178-6↗
- Qian Huang · 4 shared papers, 2016–2020 · strength 0.36
- Paper Dying tumor cell-derived exosomal miR-194-5p potentiates survival and repopulation of tumor repopulating cells upon rad… DOI 10.1186/s12943-020-01178-6↗
- Paper microRNA-193a stimulates pancreatic cancer cell repopulation and metastasis through modulating TGF-β2/TGF-βRIII signali… DOI 10.1186/s13046-018-0697-3↗
- Paper Aspirin in pancreatic cancer: chemopreventive effects and therapeutic potentials. DOI 10.1016/j.bbcan.2016.08.002↗
- Chi Fang · 3 shared papers, 2017–2021 · strength 0.31
- Paper Correction to: microRNA-193a stimulates pancreatic cancer cell repopulation and metastasis through modulating TGF-β2/TG… DOI 10.1186/s13046-021-02180-6↗
- Paper microRNA-193a stimulates pancreatic cancer cell repopulation and metastasis through modulating TGF-β2/TGF-βRIII signali… DOI 10.1186/s13046-018-0697-3↗
- Paper microRNA-7 impairs autophagy-derived pools of glucose to suppress pancreatic cancer progression. DOI 10.1016/j.canlet.2017.04.020↗
- Zhiqiang Ye · 2 shared papers, 2020–2021 · strength 0.29
- Ling Tian · 1 shared paper, 2024 · strength 0.26
- Qian Huang · 1 shared paper, 2021 · strength 0.15
- Ling Tian · 1 shared paper, 2016 · strength 0.08
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.